According to a new report by Polaris Market Research, the global clinical trial biorepository & archiving solutions market was valued at USD 4.12 billion in 2023 and is projected to reach USD 8.09 billion by 2032, expanding at a CAGR of 7.8% from 2024 to 2032. The market size is estimated at USD 4.43 billion in 2024. Growth is underpinned by rising clinical trial volumes, expanding demand for personalized medicine, and accelerating adoption of automated sample-management systems across pharmaceutical and biotechnology end-use industries.

The growing importance of clinical trial biorepository services reflects the increasing value of biological samples in modern research. Blood, tissue, DNA, and other specimens need to be collected, labeled, stored, and managed carefully so they remain useful throughout a study. The rise of biological sample storage is particularly important as clinical research becomes more data-driven and researchers seek to preserve samples for future analysis and follow-up studies.

What Is Driving Clinical Trial Biorepository & Archiving Solutions Market Growth?

Demand is climbing as expanding drug-development pipelines converge with tightening regulatory requirements for sample traceability and data integrity. Sponsors and contract research organizations are prioritizing automated sample management, pushing clinical trial biorepository & archiving solutions adoption across North America, Europe, and Asia Pacific. Polaris analysts note that the growing emphasis on data analytics and bioinformatics integration positions the clinical products segment for sustained growth through 2032, with pharmaceutical and biotech end users emerging as the largest revenue contributors and phase I trials posting the fastest incremental gains.

Key Trends Shaping the Clinical Trial Biorepository & Archiving Solutions Industry

Expansion of Automated Sample Management

The integration of automated systems in biorepositories is streamlining sample handling, storage, and retrieval, reducing human error and enabling high-throughput processing as trial volumes and sample complexity increase — a clear technology advancement trend across the industry.

Growing Focus on Data Analytics and Integration

Advanced bioinformatics platforms that merge genomic, proteomic, and clinical data are reshaping the market outlook for biorepositories, supporting personalized medicine and real-time, data-driven decision-making across research programs.

Increasing Regulatory and Compliance Requirements

Stringent FDA and EMA guidelines on sample handling and documentation are pushing providers toward more robust regulatory landscape compliance, including secure data storage, audit trails, and comprehensive tracking systems.

Explore The Complete Comprehensive Report Here:

https://www.polarismarketresearch.com/industry-analysis/biobanks-market 

Market Segmentation: Breaking Down the Clinical Trial Biorepository & Archiving Solutions Market

Polaris segments the clinical trial biorepository & archiving solutions market by product, service, phase, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Product

The clinical products segment led the market in 2023 on the strength of expansive growth in large-scale, multi-site clinical trials that demand robust, long-term sample storage. The preclinical products segment remains foundational to early-stage drug discovery, but clinical products is projected to keep outpacing it in both share and growth as trial volumes rise through 2032.

By Service

Biorepository services — spanning sample collection, processing, and storage — dominate the market and are also the fastest-growing service segment, as expanding clinical trials demand more sophisticated, automation-enabled sample-management capabilities. Archiving solution services remain a vital, if smaller, complement focused on long-term data and sample preservation.

By Phase

Phase III trials command the largest share given their scale, extensive patient cohorts, and correspondingly heavy sample-archiving needs. Phase I is the fastest-growing phase segment, propelled by rising investment in early-stage, personalized-medicine research that requires precise sample tracking from the earliest data-collection points.

Regional Outlook: Where Is Clinical Trial Biorepository & Archiving Solutions Growing Fastest?

North America led the market in 2023 on the back of advanced healthcare infrastructure, a dense concentration of pharmaceutical and biotech companies, and stringent regulatory frameworks, while Asia Pacific is expected to post strong incremental growth through 2032, driven by expanding clinical trial activity in China and India. Within North America, the United States remains the largest single market; within Asia Pacific, China and India are the primary growth engines. Europe rounds out the top three, supported by well-established clinical research infrastructure and GDPR-driven data-protection standards.

Competitive Landscape: Leading Clinical Trial Biorepository & Archiving Solutions Companies

Key players profiled in the report include Thermo Fisher Scientific, LabCorp, BioStorage Technologies, Brooks Life Sciences, and QIAGEN, alongside VWR International (part of Avantor), Sartorius AG, Hamilton Company, Precision Biobank, and CryoPort, who are focusing on technological advancements, automation, and comprehensive service offerings to strengthen market position across the clinical products and biorepository services segments outlined above. Recent moves include Cryoport's CRYOGENE partnership with Moffitt Cancer Center (January 2025) to launch on-campus biorepository services, and Thermo Fisher Scientific's acquisition of a biorepository solutions company (July 2024) to expand its sample-management and data-analytics capabilities.

Why It Matters for Buyers Evaluating Biorepository & Archiving Vendors

For stakeholders researching top clinical trial biorepository & archiving solutions companies, this report benchmarks market share, segment-level pricing, and forecast data — by product, service, phase, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing biorepository vendors, investors sizing entry points in precision medicine infrastructure, and strategy teams tracking archiving solution services as a growth adjacency.

Conclusion

The Biobanks Market is gaining momentum as pharmaceutical companies, biotechnology firms, and research organizations increasingly depend on high-quality biological samples for clinical research and drug development. Growing clinical trial activity, personalized medicine, automated sample management, and stricter requirements for sample traceability are creating new opportunities across the industry. As demand for secure collection, storage, processing, and long-term preservation of biological materials continues to rise, the Biobanks Market is expected to play an increasingly important role in supporting modern healthcare research and precision medicine.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Masterbatch Market

B2B Digital Payment Market

Urban Planning Software and Services Market

Hotel Management Software Market

Hoverboard Market

Hoverboard Market

Application Delivery Controller Market

Carbon Credit Market

Embedded AI Market